Webinar

Unlocking Precision Oncology with Genomics - ESMO Roundtable

On-demand

*This Webinar will now take place on the 16th of December at 1PM GMT*

From the European Society of Medical Oncology (ESMO) 2022 Conference in Paris, a roundtable discussion on the clinical impact of Comprehensive Genomic Profiling and how this diagnostic tool will drive the future of personalised healthcare. 

Three patient case studies are presented about the clinical utility of genomics in oncology: one about prostate cancer; one with a focus on HRD detection and diagnostics; one about liquid biopsy.

Case study 1:

Clinical utility of genomics in Oncology - Value of Comprehensive Genomic Profiling in prostate cancer, Presenter: Joaquin Mateo, MD, PhD, Vall d’Hebron Institute of Oncology, Barcelona, Spain

Case study 2:

Clinical utility of genomics in Oncology – Value of CGP with focus on HRD detection and diagnostics, Presenter: Nicole Pfarr, Head of the Molecular Diagnostic Unit/ Head of the Next Generation Research Facility, TUM, Munich, Germany

Case study 3:

Clinical utility of genomics in Oncology – Value of Comprehensive Genomic Profiling in Liquid Biopsy, Presenter: Hege G. Russnes, MD, PhD, Professor; Head, Section for exp. pathology and Research Support, Dept. of Pathology, Research group leader, Dept. of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway; Adjunct Professor, Institute of Clin. Medicine, University of Oslo, Norway

 

Webinar Learning Objectives:

  • Discover the value of comprehensive genomic profiling in solid tumors and circulating tumor DNA
  • In an greater understanding of the clinical utility of genomics in Oncology.
  • Build an understanding of the value of HRD detection and how it can be maximised with comprehensive genomic profiling.

Phil Febbo

MD, Senior Vice President & Chief Medical Officer, Illumina

Bettina Ryll

MD, PhD - MPNEurope founder, former member of the Horizon Europe Cancer Mission board, from 2015-2018 chair of ESMO Patient Advocates Working Group., Melanoma Patient Network Europe, European Society for Medical Oncology, Uppsala, Sweden

Joaquin Mateo

MD, PhD - physician-scientist and Medical Oncologist, team leader for the Prostate Cancer Translational Research Group at the Vall d´Hebron Institute of Oncology, Vall d´Hebron Institute of Oncology, Spain

Nicole Pfarr

Technical University Munich, Germany, PhD - Head of the Molecular Diagnostic Unit and Head of the Next Generation Research Facility, Technical University Munich

Hege G.Russnes

Oslo University Hospital, Norway, MD, PhD - Professor, Head of Section for Experimental Pathology and Research Support at Dept. of Pathology, Oslo University Hospital; research group leader at Dept. of Cancer Genetics, Institute for Cancer Research; adjunct Professor at the Institute of Clinical Medicine, University of Oslo